DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Jakafi (Ruxolitinib) - Published Studies


Jakafi Related Published Studies

Well-designed clinical trials related to Jakafi (Ruxolitinib)

A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers. [2013]

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. [2012]

Well-designed clinical trials possibly related to Jakafi (Ruxolitinib)

Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study. [2013]

Other research related to Jakafi (Ruxolitinib)

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts. [2014]

Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib. [2013]

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I. [2013]

Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy. [2013]

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. [2012]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017